Aa
Low-Dose PegIFN Maintenance Therapy Successful
Good news for those with cirrhosis......
http://www.natap.org/2007/EASL/EASL_58.htm
Conference Reports for NATAP
EASL---42nd Meeting of the European Association for the Study of Liver Diseases
Barcelona, Spain April 11-15, 2007
Low-Dose PegIFN Maintenance Therapy Successful
Reported by Jules Levin
EASL, April 2007, Barcelona, Spain
"LONGTERM TREATMENT WITH PEG-IFN-ALFA2B REDUCES HEPATOCELLULAR INCIDENCE AND PREVENTS CLINICAL COMPLICATIONS IN HEPATITIS C CIRRHOSIS - AN INTERIM ANALYSIS OF A MULTICENTER TRIAL"
A. Erhardt 1, U. Heinzel-Pleines 1, W. Boecher 2, H. Wedemeyer 3, M.M. Dollinger 5, F.W. Albert 6, T. Witthoeft 4, D. Haeussinger 1 1 Universitaetsklinik Duesseldorf, Duesseldorf, Germany; 2 Universitaetsklinik Mainz, Mainz, Germany; 3 Medizininische Hochschule Hannover, Hannover, Germany; 4 Universitaetsklinik Schleswig-Holstein, Schleswig-Holstein, Germany; 5 Universitaetsklinik Halle, Halle, Germany; 6 Westpfalzklinik Kaiserslautern, Kaiserslautern, Germany
Background and aims: Interferons has been shown to inhibit fibrosis progression. This multicenter, randomized, prospective trial investigated the efficacy of low-dose pegylated interferon-alpha 2b (0,35-1
http://www.natap.org/2007/EASL/EASL_58.htm
Conference Reports for NATAP
EASL---42nd Meeting of the European Association for the Study of Liver Diseases
Barcelona, Spain April 11-15, 2007
Low-Dose PegIFN Maintenance Therapy Successful
Reported by Jules Levin
EASL, April 2007, Barcelona, Spain
"LONGTERM TREATMENT WITH PEG-IFN-ALFA2B REDUCES HEPATOCELLULAR INCIDENCE AND PREVENTS CLINICAL COMPLICATIONS IN HEPATITIS C CIRRHOSIS - AN INTERIM ANALYSIS OF A MULTICENTER TRIAL"
A. Erhardt 1, U. Heinzel-Pleines 1, W. Boecher 2, H. Wedemeyer 3, M.M. Dollinger 5, F.W. Albert 6, T. Witthoeft 4, D. Haeussinger 1 1 Universitaetsklinik Duesseldorf, Duesseldorf, Germany; 2 Universitaetsklinik Mainz, Mainz, Germany; 3 Medizininische Hochschule Hannover, Hannover, Germany; 4 Universitaetsklinik Schleswig-Holstein, Schleswig-Holstein, Germany; 5 Universitaetsklinik Halle, Halle, Germany; 6 Westpfalzklinik Kaiserslautern, Kaiserslautern, Germany
Background and aims: Interferons has been shown to inhibit fibrosis progression. This multicenter, randomized, prospective trial investigated the efficacy of low-dose pegylated interferon-alpha 2b (0,35-1
illio, don't feel like you were being arrogant.... everyone who starts this therapy believes that it won't happen to them. Which actually is a good thing, that way the sides that come are true sides not a psychosomatic belief. Everyone gets some form of side effects it just depends on how hard they hit you. Hopefully they will ease up on you soon (they usually do) good luck
Nicki
Nicki
I am on the maintenance dose of INF , and what a lovely headache and fever I 'm having today .HOWEVER...
I am not complaining. I've been through what most of you
have been through and would take the nice headache and fever any day over the SX from the full combo treatment .
hang in there
viva la medicacion
I am not complaining. I've been through what most of you
have been through and would take the nice headache and fever any day over the SX from the full combo treatment .
hang in there
viva la medicacion
Have an Answer?
You are reading content posted in the Hepatitis C Community
Learn about this treatable virus.
Getting tested for this viral infection.
3 key steps to getting on treatment.
4 steps to getting on therapy.
What you need to know about Hep C drugs.
How the drugs might affect you.
These tips may up your chances of a cure.
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
